O
ISSUER//CIK 0001349426
Omrix Biopharmaceuticals, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- SC 13G/A81.2 KBOmrix Biopharmaceuticals, Inc.Feb 13, 2:31 PM ET·0001193125-09-029034
- 8-K28.7 KBOmrix Biopharmaceuticals, Inc.Sep 30, 10:58 AM ET·0001299933-08-004552
- 10-Q254.4 KBOmrix Biopharmaceuticals, Inc.Aug 11, 5:20 PM ET·0000950123-08-009317
- 8-K70.1 KBOmrix Biopharmaceuticals, Inc.Aug 11, 4:12 PM ET·0001299933-08-003852
- 8-K56.1 KBOmrix Biopharmaceuticals, Inc.Aug 11, 4:03 PM ET·0001299933-08-003849
- 8-K16.8 KBOmrix Biopharmaceuticals, Inc.May 15, 7:37 PM ET·0001299933-08-002570
- SC 13G/A70.1 KBOmrix Biopharmaceuticals, Inc.Apr 9, 2:27 PM ET·0001104659-08-023427
- SC 13G/A8.1 KBOmrix Biopharmaceuticals, Inc.Mar 10, 10:31 AM ET·0000315066-08-002342
- 8-K28.6 KBOmrix Biopharmaceuticals, Inc.Feb 5, 1:52 PM ET·0001299933-08-000615
- 46.6 KBOmrix Biopharmaceuticals, Inc.Jan 7, 11:15 AM ET·0001209191-08-002277
Insiders
10Tickers
No tickers on record
Addresses
business
630 FIFTH AVENUE, 22ND FLOOR
NEW YORK, NY, 10111
mailing
630 FIFTH AVENUE, 22ND FLOOR
NEW YORK, NY, 10111